Immune Escape After Adoptive T-cell Therapy for Malignant Gliomas.

Tyler J WildesKyle A DysonConnor FrancisBrandon WummerChanglin YangOleg YegorovDavid ShinAdam J GrippinBayli DiVita DeanRebecca AbrahamChristina PhamGinger L MooreCarmelle KuizonDuane A MitchellCatherine T Flores

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)

These findings suggest that the immune landscape of brain tumors are markedly different postimmunotherapy yet can still be targeted with immunotherapy.

Keyphrases

high grade
cell therapy
cancer therapy
single cell
stem cells
mesenchymal stem cells
drug delivery